Protective effect of polyamines on NSAID-induced injury and apoptosis

Polyamine Cell Signaling: Polyamine Cell Signaling

Volumn , Issue , 2006, Pages 267-278

  Wallace, Heather M ^a   Hughes, Alun ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68949212653     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-145-1_15     Document Type: Chapter

References (52)

1. Vane, J. R., Flower, R. J., and Botting, R. M. (1990) History of aspirin and its mechanism of action. Stroke 21, IV12-IV23.
2. Vane, J. R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirinlike drugs. Nat. New Biol. 231, 232-235.
3. Ricchi, P., Zarrilli, R., Di Palma, A., and Acquaviva, A. M. (2003) Nonsteroidal anti-inflammatory drugs in colorectal cancer: From prevention to therapy. Br. J. Cancer 88, 803-807.
4. Morita, I., Schindler, M., Regier, M. K., et al. (1995) Different intracellular locations for prostaglandin endoperoxide H synthase-1 and-2. J. Biol. Chem. 270, 10,902-10,908.
5. Smith, W. L. and DeWitt, D. L. (1995) Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin. Nephrol. 15, 179-194.
6. Charalambous, M. P., Maihofner, C., Bhambra, U., Lightfoot, T., and Gooderham, N. J. Colorectal Cancer Study Group. (2003) Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cells. Br. J. Cancer. 88, 1598-1604.
7. Wolff, H., Saukkonen, K., Anttila, S., Karjalainen, A., Vainio, H., and Ristimaki, A. (1998) Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 58, 4997-5001.
8. Tucker, O. N., Dannenberg, A. J.,Yang, E. K., et al. (1999) Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res. 59, 987-990.
9. Shiff, S. J. and Rigas, B. (1999) The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J. Exp. Med. 190, 445-450.
10. Chan, T. A. (2002) Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol. 3, 166-174.
11. McCarthy, D. M. (1999) Comparative toxicity of nonsteroidal anti-inflammatory drugs. Am. J. Med. 107, 37S-46S.
12. Lanza, F. L., Rack, M. F., Simon, T. J., et al. (1999) Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen. Aliment Pharmacol. Ther. 13, 761-767.
13. Hawkey, C. J. and Langman, M. J. (2003) Non-steroidal anti-inflammatory drugs: Overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut 52, 600-608.
14. Cronstein, B. N. and Weissmann, G. (1995) Targets for antiinflammatory drugs. Annu. Rev. Pharmacol. Toxicol. 35, 449-462.
15. Gierse, J. K., McDonald, J. J., Hauser, S. D., Rangwala, S. H., Koboldt, C. M., and Seibert, K. (1996) A single amino acid difference between cyclooxygenase-1 (COX-1) and-2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. J. Biol. Chem. 271, 15,810-15,814.
16. Cryer, B. and Dubois, A. (1998) The advent of highly selective inhibitors of cyclooxygenase- a review. Prostaglandins Other Lipid Mediat. 56, 341-361.
17. Silverstein, F. E., Faich, G., Goldstein, J. L, et al. (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284, 1247-1255.
18. del Soldato, P., Sorrentino, R., and Pinto, A. (1999) NO-aspirins: A class of new antiinflammatory and antithrombotic agents. Trends Pharmacol. Sci. 20, 319-23.
19. Bjorkman, D. J. (1998) The effect of aspirin and nonsteroidal anti-inflammatory drugs on prostaglandins. Am. J. Med. 105, 8S-12S.
20. Wallace, J. L., McKnight, W., Reuter, B. K., and Vergnolle, N. (2000) NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119, 706-714.
21. Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., and Vane, J. R. (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc. Natl. Acad. Sci. USA 96, 7563-7568.
22. Erratum in: Proc. Natl. Acad. Sci. USA (1999) 96, 9666.
23. Robert, A., Nezamis, J. E., Lancaster, C., and Hanchar, A. J. (1979) Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterol. 77, 433-443.
24. Fang, W. F., Broughton, A., and Jacobson, E. D. (1977) Indomethacin-induced intestinal inflammation. Am. J. Dig. Dis. 22, 749-760.
25. Wallace, J. L. (2000) How do NSAIDs cause ulcer disease? Baillieres Best Pract. Res. Clin. Gastroenterol. 14, 147-159.
26. Nusrat, A., Delp, C., and Madara, J. L. (1992) Intestinal epithelial restitution. Characterization of a cell culture model and mapping of cytoskeletal elements in migrating cells. J. Clin. Invest. 89, 1501-1511.
27. Szabo, I. L., Pai, R., Jones, M. K., Ehring, G. R., Kawanaka, H., and Tarnawski, A. S. (2002) Indomethacin delays gastric restitution: association with the inhibition of focal adhesion kinase and tensin phosphorylation and reduced actin stress fibers. Exp. Biol. Med. (Maywood) 227, 412-424.
28. Wang, J. Y. and Johnson, L. R. (1990) Luminal polyamines stimulate repair of gastric mucosal stress ulcers. Am. J. Physiol. 259, G584-G592.
29. Wang, J. Y., Wang, J., Golovina, V. A., Li, L., Platoshyn, O., and Yuan, J. X. (2000) Role of K(+) channel expression in polyamine-dependent intestinal epithelial cell migration. Am. J. Physiol. Cell Physiol. 278, C303-C314.
30. Rao, J. N., Li, L., Golovina, V. A., et al. (2001) Ca2+-RhoA signaling pathway required for polyamine-dependent intestinal epithelial cell migration. Am. J. Physiol. Cell Physiol. 280, C993-C1007.
31. Luk, G. D., Marton, L. J., and Baylin, S. B. (1980) Ornithine decarboxylase is important in intestinal mucosal maturation and recovery from injury in rats. Science 210, 195-198.
32. Turchanowa, L., Dauletbaev, N,, Milovic, V., and Stein, J. (2001) Nonsteroidal antiinflammatory drugs stimulate spermidine/spermine acetyltransferase and deplete polyamine content in colon cancer cells. Eur. J. Clin. Invest. 31, 887-893.
33. Hughes, A., Smith, N. I., and Wallace, H. M. (2003) Polyamines reverse non-steroidal antiinflammatory drug-induced toxicity in human colorectal cancer cells. Biochem. J. 374, 481-488.
34. Babbar, N., Ignatenko, N. A., Casero, R. A. Jr., and Gerner, E. W. (2003) Cyclooxygenaseindependent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. J. Biol. Chem. 278, 47,762-47,775.
35. Wang, J. Y. and Johnson, L. R. (1991) Polyamines and ornithine decarboxylase during repair of duodenal mucosa after stress in rats. Gastroenterol. 100, 333-343.
36. Rao, J. N., Platoshyn, O., Li, L., et al. (2002) Activation of K(+) channels and increased migration of differentiated intestinal epithelial cells after wounding. Am. J. Physiol. Cell Physiol. 282, C885-C898.
37. Guo, X., Rao, J. N., Liu, L., Rizvi, M., Turner, D. J., and Wang, J. Y. (2002) Polyamines regulate beta-catenin tyrosine phosphorylation via Ca(2+) during intestinal epithelial cell migration. Am. J. Physiol. Cell Physiol. 283, C722-C734.
38. Banan, A., McCormack, S. A., and Johnson, L. R. (1998) Polyamines are required for microtubule formation during gastric mucosal healing. Am. J. Physiol. 274, G879-G885.
39. Rao, J. N., Guo, X., Liu, L., et al. (2003) Polyamines regulate Rho-kinase and myosin phosphorylation during intestinal epithelial restitution. Am. J. Physiol. Cell Physiol. 284, C848-C859.
40. Ray, R. M., Viar, M. J., McCormack, S. A., and Johnson, L. R. (2001) Focal adhesion kinase signaling is decreased in polyamine-depleted IEC-6 cells. Am J. Physiol. Cell Physiol. 281, C475-C485.
41. Kaminska, B., Kaczmarek, L., and Grzelakowska-Sztabert, B. (1992) Inhibitors of polyamine biosynthesis affect the expression of genes encoding cytoskeletal proteins. FEBS Lett. 304, 198-200.
42. Rao, J. N., Li, L., Bass, B. L., and Wang, J. Y. (2000) Expression of the TGF-beta receptor gene and sensitivity to growth inhibition following polyamine depletion. Am. J. Physiol. Cell Physiol. 279, C1034-C1044.
43. Wong, S., Appleberg, M., Ward, C. M., and Lewis, D. R. (2004) Aspirin resistance in cardiovascular disease: A review. Eur J. Vasc. Endovasc. Surg. 27, 456-465.
44. Giardiello, F. M., Offerhaus, G. J., and DuBois, R. N. (1995) The role of nonsteroidal antiinflammatory drugs in colorectal cancer prevention. Eur. J. Cancer 31A, 1071-1076.
45. Sandler, R. S., Galanko, J. C., Murray, S. C., Helm, J. F., and Woosley, J. T. (1998) Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas. Gastroenterol. 114, 441-447.
46. Hanif, R., Pittas, A., Feng, Y., et al. (1996) Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandinindependent pathway. Biochem. Pharmacol. 52, 237-245.
47. Lindsay, G. S. and Wallace, H. M. (1999) Changes in polyamine catabolism in HL-60 human promyelogenous leukaemic cells in response to etoposide-induced apoptosis. Biochem. J. 337, 83-87.
48. Parchment, R. E. and Pierce, G. B. (1989) Polyamine oxidation, programmed cell death, and regulation of melanoma in the murine embryonic limb. Cancer Res. 49, 6680-6686.
49. Wallace, H. M., Fraser, A. V., and Hughes, A. (2003) A perspective of polyamine metabolism. Biochem. J. 376, 1-14.
50. Moffatt J, Hashimoto M, Kojima A, et al. (2000) Apoptosis induced by 1?-acetoxychavicol acetate in 49. Ehrlich ascites tumor cells is associated with modulation of polyamine metabolism and caspase-3 activation. Carcinogenesis 21, 2151-2157.
51. Parker, M. T. and Gerner, E. W. (2002) Polyamine-mediated post-transcriptional regulation of COX-2. Biochimie 84, 815-819.
52. Turini, M. E. and DuBois, R. N. (2002) Primary prevention: phytoprevention and chemoprevention of colorectal cancer. Hematol. Oncol. Clin. North Am. 16, 811-840